Peptide-based vaccination against the HER-2/neu oncogenic protein

被引:0
|
作者
Boer R.
机构
关键词
Breast cancer; HER-2/neu; Ovarian cancer; Peptide; Vaccine;
D O I
10.1186/bcr-1999-66631
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [1] Vaccination against HER-2/neu oncogenic protein
    Bernhard, H
    Salazar, L
    Schiffman, K
    Smorlesi, A
    Schmidt, B
    Knutson, KL
    Disis, ML
    ENDOCRINE-RELATED CANCER, 2002, 9 (01) : 33 - 44
  • [2] Vaccination against Her-2/neu, with focus on peptide-based vaccines
    Tobias, J.
    Garner-Spitzer, E.
    Drinic, M.
    Wiedermann, U.
    ESMO OPEN, 2022, 7 (01)
  • [3] Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, an oncogenic self-protein
    Disis, ML
    Gralow, JR
    Bernhard, H
    Hand, SL
    Rubin, WD
    Cheever, MA
    JOURNAL OF IMMUNOLOGY, 1996, 156 (09): : 3151 - 3158
  • [4] Peptide based vaccines for immunization to HER-2/neu, an oncogenic self protein
    Cheever, MA
    Disis, ML
    PATHOLOGIE BIOLOGIE, 1998, 46 (02): : 126 - 126
  • [5] Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine
    Disis, ML
    Grabstein, KH
    Sleath, PR
    Cheever, MA
    CLINICAL CANCER RESEARCH, 1999, 5 (06) : 1289 - 1297
  • [6] IMMUNITY TO THE HER-2/NEU ONCOGENIC PROTEIN
    DISIS, ML
    BERNHARD, H
    GRALOW, JR
    HAND, SL
    EMERY, SR
    CALENOFF, E
    CHEEVER, MA
    VACCINES AGAINST VIRALLY INDUCED CANCERS, 1994, 187 : 198 - 211
  • [7] Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
    Disis, ML
    Gooley, TA
    Rinn, K
    Davis, D
    Piepkorn, M
    Cheever, MA
    Knutson, KL
    Schiffman, K
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) : 2624 - 2632
  • [8] Clinical translation of peptide-based vaccine trials: The HER-2/neu model
    Disis, ML
    Knutson, KL
    McNeel, DG
    Davis, D
    Schiffman, K
    CRITICAL REVIEWS IN IMMUNOLOGY, 2001, 21 (1-3) : 263 - 273
  • [9] Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu
    Riemer, AB
    Klinger, M
    Wagner, S
    Bernhaus, A
    Mazzucchelli, L
    Pehamberger, H
    Scheiner, O
    Zielinski, CC
    Jensen-Jarolim, E
    JOURNAL OF IMMUNOLOGY, 2004, 173 (01): : 394 - 401
  • [10] Vaccination with Her-2/neu DNA or protein subunits protects against growth of a Her-2/neu-expressing murine tumor
    Foy, TM
    Bannink, J
    Sutherland, RA
    McNeill, PD
    Moulton, GG
    Smith, J
    Cheever, MA
    Grabstein, K
    VACCINE, 2001, 19 (17-19) : 2598 - 2606